The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.
A recent study published in the journal Rheumatology found six women out of 491 patients who developed a skin rash known as herpes zoster (HZ) infection — or shingles — within three to 14 days of receiving either the first or second dose of the Pfizer's COVID vaccine.
Researchers from Tel Aviv Sourasky Medical Center and Carmel Medical Center in Haifa also found the risk of developing HZ infection following a COVID vaccine increases among people with autoimmune inflammatory rheumatic diseases, Jerusalem Post reported.
Shingles occurs when the varicella zoster virus, which causes chickenpox, is reactivated after lying dormant in the cranial and spinal nerves in the body. It then travels along affected nerves to the area of the skin served by those nerves, where it causes a distinctive, stripe-like rash on one side of the face or body.